Page last updated: 2024-10-31

metyrapone and Neoplasm Regression, Spontaneous

metyrapone has been researched along with Neoplasm Regression, Spontaneous in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Neoplasm Regression, Spontaneous: Disappearance of a neoplasm or neoplastic state without the intervention of therapy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ney, RL1
Hammond, W1
Wright, L1
Davis, WW1
Acker, J1
Bartter, FC1

Other Studies

1 other study available for metyrapone and Neoplasm Regression, Spontaneous

ArticleYear
Studies in a patient with an ectopic adrenocortical tumor.
    The Journal of clinical endocrinology and metabolism, 1966, Volume: 26, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotrop

1966